GlassScriptPhysician profile
Sadiq J Al-Nakeeb
NPI 1073562450
$12,111.04
in general payments reported to CMS, 2019-2025
37 companies · $4,054 in 2025
The $4,054 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $665 · 2021: $772 · 2022: $2,013 · 2023: $1,990 · 2024: $2,616 · 2025: $4,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,571 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,570.87 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,863.49 | 2020-2025 | Fasenra, Tezspire, Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $1,419.69 | 2020-2025 | Glassia |
| Glaxosmithkline, LLC. | $1,374.68 | 2020-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Inspire Medical Systems, INC. | $1,311.19 | 2022-2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $720.07 | 2020-2025 | Ofev, Jascayd |
| Regeneron Healthcare Solutions, INC. | $526.23 | 2023-2025 | Dupixent |
| Insmed, INC. | $522.13 | 2020-2025 | Arikayce, Brinsupri |
| Grifols USA, LLC | $425.81 | 2020-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $390.07 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $369.10 | 2021-2025 | Opsumit, Uptravi, Opsynvi |
| United Therapeutics Corporation | $334.01 | 2023-2025 | Tyvaso, Tyvaso |
| Philips North America LLC | $256.69 | 2021-2025 | Vest Therapy Und |
| Merck Sharp & Dohme LLC | $246.75 | 2023-2025 | Winrevair, Zerbaxa |
| Viatris Specialty LLC | $214.14 | 2025 | Yupelri |
| Mylan Specialty L.P. | $206.37 | 2020-2024 | Yupelri |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $201.17 | 2025 | Ohtuvayre |
| Electromed, INC. | $190.61 | 2024-2025 | Smartvest |
| Resmed Corp | $179.10 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $173.47 | 2022-2025 | |
| Axsome Therapeutics, INC. | $162.83 | 2022-2024 | Sunosi |
| Amgen INC. | $124.09 | 2024-2025 | Tezspire |
| Intuitive Surgical, INC. | $121.15 | 2024 | |
| Noctrix Health, INC. | $120.98 | 2025 | Nidra |
| Jazz Pharmaceuticals INC. | $114.14 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $80.96 | 2021-2024 | Xarelto |
| Medtronic, INC. | $80.41 | 2024 | Nuvent |
| Mallinckrodt Hospital Products INC. | $55.71 | 2021 | |
| Advanced Respiratory, INC | $55.07 | 2020-2021 | |
| Baxter Healthcare | $42.39 | 2024-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Genentech USA, INC. | $39.35 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $39.07 | 2020-2021 | |
| Vapotherm INC | $38.41 | 2022 | |
| Inogen, INC. | $32.29 | 2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Avadel Cns Pharmaceuticals, LLC | $27.56 | 2024 | Lumryz |
| Covis Pharma Gmbh | $21.01 | 2022 | |
| Vifor Pharma, INC. | $19.66 | 2024 | Zemaira |
| Teva Pharmaceuticals USA, INC. | $11.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sadiq Al-Nakeeb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.